Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
July 18, 2024
Tags
U/S/ Markets
Tesla Inc
Eli Lilly and Co
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
Tags
Obesity
Eli Lilly and Co
Daily Open
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
Tags
Eli Lilly and Co
Obesity
Daily Open
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Biotech and Pharmaceuticals
Breaking News: Markets
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Pfizer Inc
UnitedHealth Group Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Health & Science
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Stock Picks
Markets
Hims & Hers Health Inc
From
CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
July 10, 2024
Tags
Investment strategy
Business
Microsoft Corp
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Sanofi SA
Business News
Biotechnology
From
CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
July 08, 2024
Tags
Investment Strategy
NVIDIA Corp
Investment strategy
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
U/S/ Markets
Stock markets
Weight management
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Cigna Corp
Technology
Health care industry
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Alzheimer's disease
Paramount Global
NVIDIA Corp
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Pharmaceuticals
Nasdaq Inc
Asia Markets
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Health & Science
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
ETF Edge
Investment strategy
Investing
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Altimmune Inc
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Stock markets
Mad Money
Investing
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
US Top News and Analysis
China Economy
Pharmaceuticals
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
US: News
Eli Lilly and Co
Business News
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Pharmaceuticals
Health & Science
Business
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Europe News
Markets
Zealand Pharma A/S
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Business
Health care industry
Companies
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Stock markets
Mad Money
Investing
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Eli Lilly and Co
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Markets
Stock Picks
RH
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Science
Merck & Co Inc
Johnson & Johnson
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Morgan Stanley
Eli Lilly and Co
Alphabet Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.